E2F1-induced transcriptional activation of MAL2 inhibits sunitinib sensitivity and promotes the malignant progression of bladder cancer
E2F1-induced transcriptional activation of MAL2 promoted the progression of BCa and inhibited sunitinib sensitivity, offering a potential novel therapeutic approach for BCa patients.
Authors
- Guangqing Fu
- Daiwei Han (ORCID: https://orcid.org/0000-0003-0225-5245)
- Wei Chen (ORCID: https://orcid.org/0000-0002-2339-5741)
- Mingqiang Su
- Xianyong Li (ORCID: https://orcid.org/0000-0002-3797-7611)
- Jingxian Luo (ORCID: https://orcid.org/0000-0002-3055-7200)
- Dayong Ye (ORCID: https://orcid.org/0000-0003-1573-8764)
Institutions
- Zigong First People's Hospital (CN)
Publication Details
- Journal
- Journal of Chemotherapy
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1080/1120009x.2025.2561275
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00